Showing 719 news articles about Side effects

Filters Content type: News Topic: Side effects

The most common side effects of anti-HIV drugs are short term and are the result of the body getting used to a new drug. Long-term adverse effects and toxicities are less common.

Kidney problems

Acute and chronic kidney disease

News
4 February 2011
Drug interactions & pharmacokinetics

High bilirubin levels may be more frequent in adolescents taking atazanavir

News
1 February 2011
Cardiovascular disease

Atorvastatin and rosuvastatin have most favourable impact on lipids of patients with HIV

News
11 January 2011
Side effects

Genetic tests could predict which patients will have problems with some anti-HIV drugs

News
7 January 2011
Diabetes

Vitamin D deficiency increases risk of type 2 diabetes for patients with HIV

News
4 January 2011
Side effects

Tenofovir with 3TC or FTC associated with lower lipid increases than other NRTI pairs

News
14 December 2010
Side effects

High triglycerides increase risk of neuropathy for patients with HIV

News
14 December 2010
Side effects

Switching from efavirenz to etravirine improves mood and sleep

News
7 December 2010
Changing treatment

No evidence that patients taking long-term efavirenz want to switch to etravirine

News
18 November 2010
Bone & joint problems

Bone loss common in patients with HIV, and often progresses

News
8 November 2010
Side effects

Reconstructive surgery for facial fat loss is feasible and safe for patients with HIV

News
2 November 2010
Kidney problems

HIV and the kidneys

News
1 November 2010
Cardiovascular disease

Drug safety bodies issue warning on heart rhythm risks with saquinavir (Invirase)

News
22 October 2010
Bone & joint problems

Switch from efavirenz or AZT associated with improvement in vitamin D levels

News
20 October 2010
Cardiovascular disease

Low CD4 cell count associated with heart attack in patients with HIV

News
7 October 2010
Cardiovascular disease

Individual risk factors crucial in determining a patient's risk of heart attack if taking abacavir

News
6 October 2010
Side effects

Treatment with tenofovir associated with more bone loss than abacavir, but long-term consequences unclear

News
29 September 2010
Changing treatment

Switch to nevirapine can happen at any CD4 count, says European drug regulator

News
17 September 2010
Hepatitis C treatment

HIV/HCV co-infected women more likely to stop HCV therapy

News
14 September 2010
PEP

Truvada/Kaletra HIV PEP combination is safe and effective with a low rate of discontinuations

News
9 September 2010
Treatment for women

Nevirapine toxicity in women predicted by liver function, not CD4 count, developing country study reports

News
1 September 2010
Health problems in children & young people

Children with HIV are at risk for metabolic problems and heart muscle dysfunction

News
21 July 2010
Treatment outcomes & life expectancy

Inflammation associated with increased mortality risk for patients with HIV, even when CD4 cell count high

News
6 July 2010
Ageing & HIV

Will a long life be a good one?

News
1 July 2010